
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Summary for Tradename: ERYTHROCIN STEARATE
|
| |||||||||
Clinical Trials for: ERYTHROCIN STEARATEComparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis Status: Active, not recruiting Condition: Gastroparesis Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes Status: Terminated Condition: Preterm Premature Ruptured Membranes Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin Status: Recruiting Condition: Epidermolysis Bullosa TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r) Status: Completed Condition: Hepatitis C Virus The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers Status: Completed Condition: Healthy A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function Status: Completed Condition: Healthy; Renal Insufficiency Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial Status: Completed Condition: Variceal Bleeding Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Status: Completed Condition: Blepharitis Neuroprotection With Erythromycin in Cardiac Surgery Status: Recruiting Condition: Functional Disturbances Following Cardiac Surgery An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet Status: Completed Condition: Healthy Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Exclusivity Expiration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | ERYTHROCIN STEARATE | erythromycin stearate | Tablet; Oral | 060359 | Approved prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbott | ERYTHROCIN STEARATE | erythromycin stearate | Tablet; Oral | 060359 | Approved prior to Jan 1, 1982 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbott | ERYTHROCIN STEARATE | erythromycin stearate | Tablet; Oral | 060359 | Approved prior to Jan 1, 1982 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc